Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Alphamab Oncology Receives NMPA CDE Acceptance for IND Application of Innovative PD-L1/VEGFR2 Bispecific ADC JSKN027 for Advanced Solid Tumors
Thursday, December 18, 2025Alphamab Oncology has secured NMPA CDE acceptance of its IND application for JSKN an innovative PDLVEGFR bispecific ADC paving the way for a Phase I trial in advanced solid tumors in China
Everest Medicines’ Partner LIB Therapeutics Secures US FDA Approval for LEROCHOL™ to Treat High LDL Cholesterol
Thursday, December 18, 2025Everest Medicines has reported that its licensing partner LIB Therapeutics has received approval from the US Food and Drug Administration FDA for LEROCHOL lerodalcibepliga
Antengene Wins Malaysian sNDA Approval Expanding XPOVIO Selinexor Indications to Relapsed or Refractory DLBCL
Wednesday, December 17, 2025Antengene has secured Malaysian NPRA approval for a supplemental NDA expanding XPOVIO selinexor to treat relapsed or refractory diffuse large Bcell lymphoma strengthening its hematology oncology portfolio in Asia Pacific
SandboxAQ Enters into Collaboration with MapLight Therapeutics to Develop CNS Therapies
Wednesday, December 17, 2025SandboxAQ and MapLight Therapeutics have entered into a strategic collaboration to discover and develop potential firstinclass therapies for central nervous system CNS disorders
RoslinCT and Ayrmid partner to manufacture Omisirge® for FDA-approved indication
Wednesday, December 17, 2025RoslinCT and Ayrmid have expanded their strategic partnership to support the commercial manufacture of Omisirge omidubicelonlv following its approval by the US Food and Drug Administration
GSK Receives Approval for Exdensur (depemokimab) to Treat Severe Asthma
Wednesday, December 17, 2025GSK has announced that the US Food and Drug Administration FDA has approved Exdensur depemokimabulaa as an addon maintenance treatment for severe asthma with an eosinophilic phenotype in adults and adolescents aged years and above
INCOG BioPharma Announces US$200 Million Expansion at Indiana
Wednesday, December 17, 2025INCOG BioPharma Services has announced a further expansion of its manufacturing operations with an investment of around US million at its facility in Fishers Indiana
Allink Biotherapeutics raises $47 million Series A extension to advance global ADC clinical programs from Shanghai base
Tuesday, December 16, 2025Shanghaibased Allink Biotherapeutics has secured a million Series A extension to accelerate its Asiaoriginated global ADC clinical programs and nextgeneration biologics platforms
AstraZeneca and Daiichi Sankyo Receives Approval for Enhertu plus pertuzumab in HER2-positive Metastatic Breast Cancer
Tuesday, December 16, 2025AstraZeneca and Daiichi Sankyo have received approval in the US for Enhertu trastuzumab deruxtecan in combination with pertuzumab for the firstline treatment of adults with unresectable
Dren Bio Enters into Collaboration with Sanofi on B-Cell Depletion Therapy
Tuesday, December 16, 2025Dren Bio has expanded its strategic collaboration with Sanofi to develop a nextgeneration Bcell depleting therapy aimed at treating a range of autoimmune diseases
